Indian ADRs: Holding out - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian ADRs: Holding out

Apr 28, 2001

After having rallied significantly earlier in April, the US markets seem to be taking a breather with profit booking having set in. The rally has drawn mixed reactions, with some labeling it a dead cat bounce. Others believe that the worst is probably over. So far in April, the Dow has gained 13.6% and the NASDAQ 16.3%.

Indices 20-Apr 27-Apr Change
Dow 10,579.9 10,810.1 2.2%
Nasdaq 2,163.4 2,075.7 -4.1%
Nikkei 13,765.7 13,934.3 1.2%
Hang Seng 13,448.1 13,386.0 -0.5%
Sensex 3,583.0 3,423.0 -4.5%

Indian ADRs posted a mixed performance, on the back of the sharp gains recorded last week. While Infy logged in gains, ICICI Bank was a significant loser. The fall in ICICI Bank can in part be attributed to the rumored losses the company has suffered in its capital markets operations (lending to brokers). Infy on the other hand appeared to be stabilizing at existing levels after its much publicized warning earlier this month.

(US$) 20-Apr 27-Apr Change
Infosys 63 66.3 5.2%
Satyam Infoway 4 4.1 2.5%
ICICI 12.2 11.9 -2.9%
ICICI Bank 7.4 6.6 -11.1%
Wipro 29 29.1 0.4%
VSNL 13.4 13.1 -2.0%
Dr. Reddy's 11.3 11.7 3.1%
Silverline 4.1 4.0 -2.2%
Rediff.com 4.2 4.0 -6.0%

Rediff too has been among the prominent losers. This was because the company reported lower than expected growth in turnover. For the year ended March 2001 Rediff reported nearly 140% growth in revenues and reduced its loss for the period by 4% to US$ 6.4 m. However, Rediff saw some heavy spurts during the week as most analysts had still recommended a buy on this Indian ADR.

New entrant Dr. Reddy however, continued its steady climb. The pharma major has been continually stating that it will continue to focus on Research and Development of new molecules for clinical trials.

However, over the past week as the NASDAQ fell over 4%, Indian tech ADRs counters led by Infosys gained. Though Indian tech majors are expected to show a slowdown in growth, a lot of these companies are still expected to sustain a healthy grow rate. The same may not be the case for a lot of US technology companies. Though it may be too early to say this, but it sure looks like a sign that the investors are now segregating their buying actions based on regional factors.

Given the slowdown in both the Indian and US economies a sustained recovery in the Indian ADRs (especially the TMT stocks) seems to be unlikely. Added to that Sebiís recommendations on ban of carry forward transactions will also impede a recovery of the Indian bourses, atleast in the short term.


Equitymaster requests your view! Post a comment on "Indian ADRs: Holding out ". Click here!

  

More Views on News

AVANTI FEEDS Announces Quarterly Results (1QFY21); Net Profit Up 14.1% (Quarterly Result Update)

Aug 28, 2020 | Updated on Aug 28, 2020

For the quarter ended June 2020, AVANTI FEEDS has posted a net profit of Rs 1 bn (up 14.1% YoY). Sales on the other hand came in at Rs 10 bn (down 12.6% YoY). Read on for a complete analysis of AVANTI FEEDS's quarterly results.

RELAXO FOOTWEARS Announces Quarterly Results (1QFY21); Net Profit Down 51.3% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, RELAXO FOOTWEARS has posted a net profit of Rs 242 m (down 51.3% YoY). Sales on the other hand came in at Rs 4 bn (down 43.9% YoY). Read on for a complete analysis of RELAXO FOOTWEARS's quarterly results.

FORTIS HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Oct 18, 2019 | Updated on Oct 18, 2019

Here's an analysis of the annual report of FORTIS HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of FORTIS HEALTHCARE. Also includes updates on the valuation of FORTIS HEALTHCARE.

THOMAS COOK INDIA 2018-19 Annual Report Analysis (Annual Result Update)

Oct 18, 2019 | Updated on Oct 18, 2019

Here's an analysis of the annual report of THOMAS COOK INDIA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of THOMAS COOK INDIA. Also includes updates on the valuation of THOMAS COOK INDIA.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

More Views on News

Most Popular

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

My Top Stock to Buy in this Market Selloff (Profit Hunter)

Sep 22, 2020

The recent correction offers a great opportunity to buy this high conviction smallcap stock.

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...

Can the Nifty Fall to 10,200? (Fast Profits Daily)

Sep 24, 2020

The Nifty has reached an important support level today. If it breaks then we could see further downside.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

COMPARE COMPANY

MARKET STATS